{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T01:15:31Z","timestamp":1792113331424,"version":"4.4.0"},"reference-count":12,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,12,12]]},"DOI":"10.7759\/cureus.50401","type":"journal-article","created":{"date-parts":[[2023,12,12]],"date-time":"2023-12-12T19:21:13Z","timestamp":1702408873000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Bicuspid Aortic Valve Disease in an Adult Cystic Fibrosis Patient"],"prefix":"10.7759","author":[{"given":"Jason Y","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samra Haroon","family":"Lodhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Anstead","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Misumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taha","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jscai.2022.100506","article-title":"Imaging, treatment options, patient selection, and outcome considerations for patients with bicuspid aortic valve disease","volume":"1","author":"Ahmad Y","year":"2022","unstructured":"Ahmad Y, Agarwal V, Williams M, et al.. Imaging, treatment options, patient selection, and outcome considerations for patients with bicuspid aortic valve disease. Journal of the Society for Cardiovascular Angiography & Interventions. 2022, 1:100506. 10.1016\/j.jscai.2022.100506","journal-title":"Journal of the Society for Cardiovascular Angiography & Interventions"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2013.09.024","article-title":"Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve)","volume":"63","author":"Dvir D","year":"2014","unstructured":"Dvir D, Waksman R, Barbash IM, et al.. Outcomes of patients with chronic lung disease and severe aortic stenosis treated with transcatheter versus surgical aortic valve replacement or standard therapy: insights from the PARTNER trial (placement of AoRTic TraNscathetER Valve). J Am Coll Cardiol. 2014, 63:269-79. 10.1016\/j.jacc.2013.09.024","journal-title":"J Am Coll Cardiol"},{"key":"ref3","article-title":"Cystic fibrosis","author":"Yu E","year":"2023","unstructured":"Yu E, Sharma S. Cystic fibrosis. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023. https:\/\/pubmed.ncbi.nlm.nih.gov\/29630258\/:"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1016\/j.mayocp.2018.01.020","article-title":"Management of patients with aortic valve\u00a0stenosis","volume":"93","author":"Kanwar A","year":"2018","unstructured":"Kanwar A, Thaden JJ, Nkomo VT. Management of patients with aortic valve\u00a0stenosis. Mayo Clin Proc. 2018, 93:488-508. 10.1016\/j.mayocp.2018.01.020","journal-title":"Mayo Clin Proc"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)32542-3","article-title":"Cystic fibrosis","volume":"397","author":"Shteinberg M","year":"2021","unstructured":"Shteinberg M, Haq IJ, Polineni D, Davies JC. Cystic fibrosis. Lancet. 2021, 397:2195-211. 10.1016\/S0140-6736(20)32542-3","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1111\/echo.14375","article-title":"Elastic aortic properties in cystic fibrosis adults without cardiovascular risk factors: a case-control study","volume":"36","author":"Vizzardi E","year":"2019","unstructured":"Vizzardi E, Sciatti E, Bonadei I, et al.. Elastic aortic properties in cystic fibrosis adults without cardiovascular risk factors: a case-control study. Echocardiography. 2019, 36:1118-22. 10.1111\/echo.14375","journal-title":"Echocardiography"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcf.2012.11.012","article-title":"Left ventricular and aortic dysfunction in cystic fibrosis mice","volume":"12","author":"Sellers ZM","year":"2013","unstructured":"Sellers ZM, Kovacs A, Weinheimer CJ, Best PM. Left ventricular and aortic dysfunction in cystic fibrosis mice. J Cyst Fibros. 2013, 12:517-24. 10.1016\/j.jcf.2012.11.012","journal-title":"J Cyst Fibros"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcin.2019.06.037","article-title":"Temporal trends and outcomes of transcatheter versus surgical aortic valve\u00a0replacement for bicuspid aortic\u00a0valve\u00a0stenosis","volume":"12","author":"Elbadawi A","year":"2019","unstructured":"Elbadawi A, Saad M, Elgendy IY, et al.. Temporal trends and outcomes of transcatheter versus surgical aortic valve\u00a0replacement for bicuspid aortic\u00a0valve\u00a0stenosis. JACC Cardiovasc Interv. 2019, 12:1811-22. 10.1016\/j.jcin.2019.06.037","journal-title":"JACC Cardiovasc Interv"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.21037\/acs.2017.09.15","article-title":"Pros and cons of transcatheter aortic valve implantation (TAVI)","volume":"6","author":"Terr\u00e9 JA","year":"2017","unstructured":"Terr\u00e9 JA, George I, Smith CR. Pros and cons of transcatheter aortic valve implantation (TAVI). Ann Cardiothorac Surg. 2017, 6:444-52. 10.21037\/acs.2017.09.15","journal-title":"Ann Cardiothorac Surg"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-4453(05)80005-2","article-title":"Bacteraemia and fungaemia in adults with cystic fibrosis","volume":"22","author":"Fahy JV","year":"1991","unstructured":"Fahy JV, Keoghan MT, Crummy EJ, FitzGerald MX. Bacteraemia and fungaemia in adults with cystic fibrosis. J Infect. 1991, 22:241-5. 10.1016\/s0163-4453(05)80005-2","journal-title":"J Infect"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2022.11.028","article-title":"Infective endocarditis after transcatheter aortic valve replacement: JACC state-of-the-art review","volume":"81","author":"Del Val D","year":"2023","unstructured":"Del Val D, Panagides V, Mestres CA, Mir\u00f3 JM, Rod\u00e9s-Cabau J. Infective endocarditis after transcatheter aortic valve replacement: JACC state-of-the-art review. J Am Coll Cardiol. 2023, 81:394-412. 10.1016\/j.jacc.2022.11.028","journal-title":"J Am Coll Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/eurheartj\/ehv756","article-title":"TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation","volume":"37","author":"Puri R","year":"2016","unstructured":"Puri R, Iung B, Cohen DJ, Rod\u00e9s-Cabau J. TAVI or No TAVI: identifying patients unlikely to benefit from transcatheter aortic valve implantation. Eur Heart J. 2016, 37:2217-25. 10.1093\/eurheartj\/ehv756","journal-title":"Eur Heart J"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/213945-severe-bicuspid-aortic-valve-disease-in-an-adult-cystic-fibrosis-patient","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:09:51Z","timestamp":1707509391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/213945-severe-bicuspid-aortic-valve-disease-in-an-adult-cystic-fibrosis-patient"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,12]]},"references-count":12,"URL":"https:\/\/doi.org\/10.7759\/cureus.50401","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,12,12]]}}}